ReviewZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2026
[Research on tissue regeneration and engineered scaffold materials in prevention and treatment of lymphedema].
Review in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To summarize the research in tissue regeneration and engineered scaffold materials for the prevention and treatment of lymphedema. Methods: The recent domestic and international literature about lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials for the prevention and treatment of lymphedema was extensively reviewed and summarized, and the progress of tissue engineered scaffold materials in prevention and treatment of lymphedema was emphatically introduced. Results: Lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials utilize two main strategies to prevent and treat lymphedema: promoting lymphatic network regeneration Conclusion: Tissue regeneration and engineered scaffold materials provide new approaches for the prevention and treatment of lymphedema. Although innovative developments have been made, most are still at the basic research stage, and clinical translation remains a challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.